株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の核医学市場の分析と予測:製品(診断、治療薬)、用途別

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 726461
出版日 ページ情報 英文 80 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.83円で換算しております。
世界の核医学市場の分析と予測:製品(診断、治療薬)、用途別 Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月12日 ページ情報: 英文 80 Pages
概要

当レポートでは、世界の核医学市場を調査し、市場の概要、製品・用途・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 調査方法
  • 調査範囲と前提
  • 略語のリスト

第2章 エグゼクティブサマリー

  • 市場概要

第3章 市場変数、動向、範囲

  • 市場区分

第4章 市場の定義

第5章 産業の展望

  • 成長要因の分析
    • 癌および心血管疾患の罹患率の上昇
    • 核医学の用途拡大
    • 正確な診断法に対するニーズの高まり
  • 阻害要因の分析
    • 生産、貯蔵、使用における厳格な規制
    • 核医学による診断・治療コストの高さ

第6章 ビジネス環境解析

  • SWOT分析
  • ファイブフォース分析
  • バリューチェーン分析

第7章 規制と政治的要因

  • 規制環境
  • 生産工程と動向

第8章 世界の核医学市場の分析と予測:製品別

  • 市場動向の分析:製品別

第9章 世界の核医学市場の分析と予測:用途別

  • 市場動向の分析:用途別

第10章 世界の核医学市場の分析と予測:地域別

  • 市場動向の分析:地域別

第11章 企業プロファイル

  • Eckert & Ziegler Group
  • Mallinckrodt
  • GE Healthcare
  • Jubilant Life Sciences Ltd.
  • Bracco Imaging S.P.A
  • Nordion, Inc.
  • The Institute For Radioelements (IRE)
  • Australian Nuclear Science & Technology Organization (ANSTO)
  • NTP Radioisotopes SOC Ltd.
  • Eczacibasi - Monrol

第12章 キーオピニオンリーダーの解説

  • 重要な分析
  • キーオピニオンリーダーの見解

第13章 推奨事項

図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Global producers of Mo-99
  • Table 3 New projects expected to produce Mo-99
  • Table 4 List of key distributors
  • Table 5 List of key emerging companies /technology disruptors/innovators
  • Table 6 North America Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 7 North America Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 8 North America Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 9 North America Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 10 North America Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 11 North America Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 12 North America Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 13 North America Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 14 North America Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 15 U.S. Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 16 U.S. Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 17 U.S. Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 18 U.S. Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 23 U.S. Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 24 Canada Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 25 Canada Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 26 Canada Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 27 Canada Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 28 Canada Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 29 Canada Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 30 Canada Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 31 Canada Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 32 Canada Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 33 Europe Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 34 Europe Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 35 Europe Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 36 Europe Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 37 Europe Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 38 Europe Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 39 Europe Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 40 Europe Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 41 Europe Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 42 Germany Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 43 Germany Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table44 Germany Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 45 Germany Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 46 Germany Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 47 Germany Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 48 Germany Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 49 Germany Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 50 Germany Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 51 U.K. Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 52 U.K. Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 53 U.K. Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 54 U.K. Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 55 U.K. Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 56 U.K. Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 57 U.K. Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 58 U.K. Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 59 U.K. Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 60 France Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 61 France Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 62 France Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 63 France Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 64 France Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 65 France Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 66 France Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 67 France Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 68 France Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 69 Italy Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 70 Italy Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 71 Italy Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 72 Italy Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 73 Italy Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 74 Italy Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 75 Italy Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 76 Italy Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 77 Italy Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 78 Spain Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 79 Spain Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 80 Spain Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 81 Spain Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 82 Spain Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 83 Spain Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 84 Spain Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 85 Spain Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 86 Spain Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 87 Russia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 88 Russia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 89 Russia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 90 Russia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 91 Russia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 92 Russia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 93 Russia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 94 Russia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 95 Russia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 96 Netherlands Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 97 Netherlands Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 98 Netherlands Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 99 Netherlands Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 100 Netherlands Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 101 Netherlands Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 102 Netherlands Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 103 Netherlands Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 104 Netherlands Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 105 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 106 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 107 Asia Pacific Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 108 Asia Pacific Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 109 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 111 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 112 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 113 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 114 Asia Pacific Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 115 Japan Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 116 Japan Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 117 Japan Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 118 Japan Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 119 Japan Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 120 Japan Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 121 Japan Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 122 Japan Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 123 Japan Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 124 China Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 125 China Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 126 China Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 127 China Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 128 China Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 129 China Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 130 China Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 131 China Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 132 China Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 133 India Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 134 India Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 135 India Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 136 India Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 137 India Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 138 India Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 139 India Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 140 India Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 141 India Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 142 Australia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 143 Australia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 144 Australia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 145 Australia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 146 Australia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 147 Australia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 148 Australia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 149 Australia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 150 Australia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 151 Singapore Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 152 Singapore Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 153 Singapore Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 154 Singapore Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 155 Singapore Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 156 Singapore Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 157 Singapore Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 158 Singapore Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 159 Singapore Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 160 Malaysia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 161 Malaysia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 162 Malaysia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 163 Malaysia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 164 Malaysia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 165 Malaysia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 166 Malaysia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 167 Malaysia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 168 Malaysia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 169 New Zealand Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 170 New Zealand Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 171 New Zealand Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 172 New Zealand Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 173 New Zealand Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 174 New Zealand Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 175 New Zealand Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 176 New Zealand Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 177 New Zealand Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 178 South Korea Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 179 South Korea Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 180 South Korea Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 181 South Korea Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 182 South Korea Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 183 South Korea Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 184 South Korea Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 185 South Korea Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 186 South Korea Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 187 Philippines Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 188 Philippines Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 189 Philippines Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 190 Philippines Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 191 Philippines Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 192 Philippines Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 193 Philippines Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 194 Philippines Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 195 Philippines Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 196 Latin America Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 197 Latin America Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 198 Latin America Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 199 Latin America Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 200 Latin America Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 201 Latin America Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 202 Latin America Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 203 Latin America Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 204 Latin America Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 205 Brazil Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 206 Brazil Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 207 Brazil Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 208 Brazil Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 209 Brazil Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 210 Brazil Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 211 Brazil Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 212 Brazil Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 213 Brazil Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 214 Mexico Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 215 Mexico Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 216 Mexico Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 217 Mexico Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 218 Mexico Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 219 Mexico Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 220 Mexico Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 221 Mexico Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 222 Mexico Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 223 Argentina Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 224 Argentina Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 225 Argentina Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 226 Argentina Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016-2027 (USD Million)
  • TABLE 227 Argentina Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 228 Argentina Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 229 Argentina Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 230 Argentina Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 231 Argentina Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 232 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 233 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 234 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 235 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 236 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 237 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 238 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 239 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 240 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 241 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 242 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 243 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product2016 - 2027 (USD Million)
  • TABLE 244 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 245 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 246 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 247 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 248 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 249 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 250 South Africa Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 251 South Africa Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 252 South Africa Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 253 South Africa Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 254 South Africa Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 255 South Africa Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 256 South Africa Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 257 South Africa Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 258 South Africa Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 259 Israel Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 260 Israel Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 261 Israel Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 262 Israel Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 263 Israel Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 264 Israel Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 265 Israel Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 266 Israel Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 267 Israel Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
  • Table 268 Turkey Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 269 Turkey Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
  • Table 270 Turkey Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 271 Turkey Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
  • TABLE 272 Turkey Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 273 Turkey Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 274 Turkey Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
  • TABLE 275 Turkey Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
  • Table 276 Turkey Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Radiopharmaceuticals/nuclear medicine market snapshot
  • Fig. 2 Radiopharmaceuticals market segmentation
  • Fig. 3 Radiopharmaceuticals/nuclear medicine market driver impact
  • Fig. 4 Global Cancer Prevalence projection,2015 - 2025 (Number of registered cases)
  • Fig. 5 Radiopharmaceuticals market restraint impact
  • Fig. 6 SWOT analysis, by factor (political & legal economic and technological)
  • Fig. 7 Porter's five forces analysis
  • Fig. 8 Value chain analysis
  • Fig. 9 Radiopharmaceuticals Market: Production of Tc-99 (SPECT radioisotopes)
  • Fig. 10 Radiopharmaceuticals Market: Production of Mo-99
  • Fig. 11 Radiopharmaceuticals Market: Production of Mo-98
  • Fig. 12 Radiopharmaceuticals/Nuclear Medicine Market: Product outlook and key takeaways
  • Fig. 13 Radiopharmaceuticals/Nuclear Medicine Market: Product movement analysis
  • Fig. 14 Diagnostic products market, 2016 - 2027 (USD Million)
  • Fig. 15 SPECT products market, 2016 - 2027 (USD Million)
  • Fig. 16 TC-99m market, 2016 - 2027 (USD Million)
  • Fig. 17 TL-201 market, 2016 - 2027 (USD Million)
  • Fig. 18 GA-67 market, 2016 - 2027 (USD Million)
  • Fig. 19 I-123 market, 2016 - 2027 (USD Million)
  • Fig. 20 Other SPECT products market, 2016 - 2027 (USD Million)
  • Fig. 21 PET products market, 2016 - 2027 (USD Million)
  • Fig. 22 F-18 market, 2016 - 2027 (USD Million)
  • Fig. 23 SR-82/RB-82 market, 2016 - 2027 (USD Million)
  • Fig. 24 Other PET products market, 2016 - 2027 (USD Million)
  • Fig. 25 Therapeutic products market, 2016 - 2027 (USD Million)
  • Fig. 26 Alpha emitters market, 2016 - 2027 (USD Million)
  • Fig. 27 RA-223 market, 2016 - 2027 (USD Million)
  • Fig. 28 Other alpha emitters market, 2016 - 2027 (USD Million)
  • Fig. 29 Beta emitters market, 2016 - 2027 (USD Million)
  • Fig. 30 I-131 market, 2016 - 2027 (USD Million)
  • Fig. 31 Y-90 market, 2016 - 2027 (USD Million)
  • Fig. 32 SM-153 market, 2016 - 2027 (USD Million)
  • Fig. 33 Re-186 market, 2016 - 2027 (USD Million)
  • Fig. 34 Lu-177 market, 2016 - 2027 (USD Million)
  • Fig. 35 Other beta emitters market, 2016 - 2027 (USD Million)
  • Fig. 36 Brachytherapy market, 2016 - 2027 (USD Million)
  • Fig. 37 Cesium-131 market, 2016 - 2027 (USD Million)
  • Fig. 38 Iodine-125 market, 2016 - 2027 (USD Million)
  • Fig. 39 Palladium-103 market, 2016 - 2027 (USD Million)
  • Fig. 40 Iridium-192 market, 2016 - 2027 (USD Million)
  • Fig. 41 Other Brachytherapy Products Market, 2016 - 2027 (USD Million)
  • Fig. 42 Radiopharmaceuticals/Nuclear Medicine Market: application outlook and key takeaways
  • Fig. 43 Radiopharmaceuticals/Nuclear Medicine market: Application movement analysis
  • Fig. 44 Cardiology applications market, 2016 - 2027 (USD Million)
  • Fig. 45 Neurology applications market, 2016 - 2027 (USD Million)
  • Fig. 46 Oncology applications market, 2016 - 2027 (USD Million)
  • Fig. 47 Thyroid applications market, 2016 - 2027 (USD Million)
  • Fig. 48 Lymphoma applications market, 2016 - 2027 (USD Million)
  • Fig. 49 Bone metastasis applications market, 2016 - 2027 (USD Million)
  • Fig. 50 Endocrine tumor market, 2016 - 2027 (USD Million)
  • Fig. 51 Other applications market, 2016 - 2027 (USD Million)
  • Fig. 52 Radiopharmaceuticals/Nuclear Medicine market: Regional outlook and key takeaways
  • Fig. 53 Radiopharmaceuticals/Nuclear Medicine Market: Regional Movement Analysis
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecast, 2016 - 2027
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecast, 2016 - 2027
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecast, 2016 - 2027
  • Fig. 60 Europe
  • Fig. 61 Europe market estimates and forecast, 2016 - 2027
  • Fig. 62 Germany
  • Fig. 63 Germany market estimates and forecast, 2016 - 2027
  • Fig. 64 U.K.
  • Fig. 65 U.K. market estimates and forecast, 2016 - 2027
  • Fig. 66 France
  • Fig. 67 France market estimates and forecast, 2016 - 2027
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecast, 2016 - 2027
  • Fig. 70 Spain
  • Fig. 71 Spain market estimates and forecast, 2016 - 2027
  • Fig. 72 Russia
  • Fig. 73 Russia market estimates and forecast, 2016 - 2027
  • Fig. 74 Netherlands
  • Fig. 75 Netherlands market estimates and forecast, 2016 - 2027
  • Fig. 76 Asia Pacific
  • Fig. 77 Asia Pacific market estimates and forecast, 2016 - 2027
  • Fig. 78 Japan
  • Fig. 79 Japan market estimates and forecast, 2016 - 2027
  • Fig. 80 China
  • Fig. 81 China market estimates and forecast, 2016 - 2027
  • Fig. 82 India
  • Fig. 83 India market estimates and forecast, 2016 - 2027
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2016 - 2027
  • Fig. 86 Singapore
  • Fig. 87 Singapore market estimates and forecast, 2016 - 2027
  • Fig. 88 Malaysia
  • Fig. 89 Malaysia market estimates and forecast, 2016 - 2027
  • Fig. 90 New Zealand
  • Fig. 91 New Zealand market estimates and forecast, 2016 - 2027
  • Fig. 92 South Korea
  • Fig. 93 South Korea market estimates and forecast, 2016 - 2027
  • Fig. 94 Philippines
  • Fig. 95 Philippines market estimates and forecast, 2016 - 2027
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecast, 2016 - 2027
  • Fig. 98 Brazil
  • Fig. 99 Brazil market estimates and forecast, 2016 - 2027
  • Fig. 100 Mexico
  • Fig. 101 Mexico market estimates and forecast, 2016 - 2027
  • Fig. 102 Argentina
  • Fig. 103 Argentina market estimates and forecast, 2016 - 2027
  • Fig. 104 Middle East & Africa
  • Fig. 105 Middle East and Africa market estimates and forecast, 2016 - 2027
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia. market estimates and forecast, 2016 - 2027
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecast, 2016 - 2027
  • Fig. 110 Israel
  • Fig. 111 Israel Market Estimates And Forecast, 2016 - 2027
  • Fig. 112 Turkey
  • Fig. 113 Turkey market estimates and forecast, 2016 - 2027
  • Fig. 114 Company Profile
目次
Product Code: GVR-1-68038-086-6

The global nuclear medicine market size is expected to reach USD 12.6 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Research and development of advanced technologies by the key players for diagnosis and treatment of diseases is expected to drive the radiopharmaceuticals market.

For instance, in May 2019, GE Healthcare with Indi Molecular, Inc., collaborated to develop Protein Catalyzed Capture (PCC) technology and immune cell-targeted PET tracer candidates. This diagnostic tool will help in better understanding of patient's immune cell and in early treatment response.

Rising prevalence of cancer and cardiovascular diseases is one of the major factors responsible for market growth. Moreover, high prevalence of cancer in emerging Asian countries is creating huge demand for radiopharmaceuticals in diagnosing the disease. For instance, according to the GLOBOCAN, in 2018, approximately 48.4% of cancer cases were registered in Asia.

In addition, presence of standard guidelines prepared by regulatory authorities for radiopharmaceuticals is expected to accelerate market growth. For instance, in August 2019, FDA published a guideline for non-clinical studies and product labelling that are not covered by FDA and ICH guidelines for radiopharmaceuticals used in the treatment of cancer.

Manufacturers are focusing on development of innovative technologies to produce medical isotopes that can fulfill the increasing demand for nuclear medicines. For instance, in October 2018, with the support of ASML, The Institute For Radioelements (IRE) developed and built an electron beamline to manufacture medical isotope molybdenum 99 (Mo-99). Due to this innovative technology, the process of production is waste-free and non-fission.

In addition, research centers and hospitals are launching novel nuclear medicine techniques to treat various diseases at an affordable cost as compared to the existing treatments. For instance, in August 2017, the Kovai Medical Centre and Hospital (KMCH) had launched Rhenium 188 Lipiodol to treat liver cancer and other diseases such as metastatic bone pain, rheumatoid arthritis, and hemophilic bleeding joints at low cost with lesser hospitalization.

Further key findings from the study suggest:

  • In 2019, the SPECT segment had dominated the market owing to integration of SPECT with X-ray/CT that has gained more acceptance and proved to be useful in many clinical situations due to its high accuracy
  • PET diagnostic nuclear medicine is expected to witness the fastest growth over the forecast period owing to the increasing adoption of high resolution PET scanners
  • In case of the therapeutic segment, brachytherapy is anticipated to be the fastest growing segment due to the higher radiation protection as compared to other treatment options
  • The oncology application segment dominated the nuclear medicine market in 2019 owing to the presence of pipeline drugs and high prevalence of cancer
  • The market in Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and development of radiopharmaceuticals for diagnosis and treatment of various diseases

Key players in the market include companies such as Eckert and Ziegler Group Nordion, Inc.; Bracco Imaging S.p.A.; and GE Healthcare as well as government organizations such as Department of Atomic Energy and Australian Nuclear Science and Technology Organization (ANSTO).

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope and Assumptions
  • 1.3 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook

  • 5.1 Market variable Analysis
    • 5.1.1 Rising incidence of cancer and cardiovascular diseases
    • 5.1.2 Increasing application of radiopharmaceuticals
    • 5.1.3 Growing demand for accurate diagnostic methods
    • 5.1.4 Market Restraint Analysis
      • 5.1.4.1 Stringent regulations pertaining to production, storage, & usage
      • 5.1.4.2 High costs associated with diagnostics & therapeutic procedures

Chapter 6 Business Environment Analysis

    • 6.1.1 SWOT Analysis; By factor (POLITICAL & Legal, economic and technological)
    • 6.1.2 Porter's five forces analysis
    • 6.1.3 Value chain analysis

Chapter 7 Regulatory and Political Forces

  • 7.1 Regulatory Landscape
    • 7.1.1 List of factors/ regulations by country
      • 7.1.1.1 North America
      • 7.1.1.1.1 U.S.
      • 7.1.1.1.2 Canada
      • 7.1.1.2 Europe
      • 7.1.1.2.1 Germany
      • 7.1.1.2.2 U.K.
      • 7.1.1.2.3 France
      • 7.1.1.2.4 Italy
      • 7.1.1.2.5 Spain
      • 7.1.1.2.6 Russia
      • 7.1.1.2.7 Netherlands
      • 7.1.1.3 Asia Pacific
      • 7.1.1.3.1 China
      • 7.1.1.3.2 Japan
      • 7.1.1.3.3 India
      • 7.1.1.3.4 Australia
      • 7.1.1.3.5 New Zealand
      • 7.1.1.3.6 South Korea
      • 7.1.1.3.7 Singapore
      • 7.1.1.3.8 Malaysia
      • 7.1.1.3.9 Philippines
      • 7.1.1.4 Latin America
      • 7.1.1.4.1 Brazil
      • 7.1.1.4.2 Mexico
      • 7.1.1.4.3 Argentina
      • 7.1.1.5 Middle East & Africa
      • 7.1.1.5.1 South Africa
      • 7.1.1.5.2 GCC
  • 7.2 Production Process And Trends
    • 7.2.1 Production of molybdenum-99 (SPECT radioisotopes)
      • 7.2.1.1 SPECT radioisotopes trends
      • 7.2.1.2 PET radioisotopes Trends
      • 7.2.1.3 Therapeutic radioisotopes trends
      • 7.2.1.4 Latest Developments

Chapter 8 Competitive Analysis

  • 8.1 Vendor Landscape
    • 8.1.1 List of key distributors and channel partners
    • 8.1.2 Key company market share analysis, 2019
  • 8.2 Public Companies
    • 8.2.1 Company market position analysis
    • 8.2.2 Competitive Dashboard Analysis
  • 8.3 Private Companies
    • 8.3.1 List of key emerging companies /technology disruptors/innovators
    • 8.3.2 Regional network map

Chapter 9 Product Business Analysis

  • 9.1 Radiopharmaceuticals/Nuclear Medicine Market: Product Movement Analysis
  • 9.2 Diagnostic Products
    • 9.2.1 Diagnostic products market, 2016 - 2027 (USD Million)
      • 9.2.1.1 SPECT
      • 9.2.1.1.1 SPECT products market, 2016 - 2027 (USD Million)
      • 9.2.1.1.2 TC-99m
      • 9.2.1.1.3 TC-99m market, 2016 - 2027 (USD Million)
      • 9.2.1.1.4 TL-201
      • 9.2.1.1.5 TL-201 market, 2016 - 2027 (USD Million)
      • 9.2.1.1.6 GA-67
      • 9.2.1.1.7 GA-67 market, 2016 - 2027 (USD Million)
      • 9.2.1.1.8 I-123
      • 9.2.1.1.9 I-123 market, 2016 - 2027 (USD Million)
      • 9.2.1.1.10 Other SPECT products
      • 9.2.1.1.11 Other SPECT products market, 2016 - 2027 (USD Million)
      • 9.2.1.2 PET
      • 9.2.1.2.1 PET products market, 2016 - 2027(USD Million)
      • 9.2.1.2.2 F-18
      • 9.2.1.2.3 F-18 market, 2016 - 2027 (USD Million)
      • 9.2.1.2.4 SR-82/RB-82
      • 9.2.1.2.5 SR-82/RB-82 market, 2016 - 2027 (USD Million)
      • 9.2.1.2.6 Other PET products
      • 9.2.1.2.7 Other PET products market, 2016 - 2027 (USD Million)
  • 9.3 Therapeutic Products
    • 9.3.1 Therapeutic products market, 2016 - 2027 (USD Million)
    • 9.3.2 Alpha emitters
      • 9.3.2.1 Alpha emitters market, 2016 - 2027 (USD Million)
      • 9.3.2.1.1 RA-223
      • 9.3.2.1.1.1 RA-223 market, 2016 - 2027 (USD Million)
      • 9.3.2.1.2 Other alpha emitters
      • 9.3.2.1.3 Other alpha emitters market, 2016 - 2027 (USD Million)
    • 9.3.3 Beta emitters
      • 9.3.3.1 Beta emitters market, 2016 - 2027 (USD Million)
      • 9.3.3.2 I-131
      • 9.3.3.2.1 I-131 market, 2016 - 2027 (USD Million)
      • 9.3.3.3 Y-90
      • 9.3.3.3.1 Y-90 market, 2016 - 2027 (USD Million)
      • 9.3.3.4 SM-153
      • 9.3.3.4.1 SM-153 market, 2016 - 2027 (USD Million)
      • 9.3.3.5 Re-186
      • 9.3.3.5.1 Re-186 market, 2016 - 2027 (USD Million)
      • 9.3.3.6 Lu-117
      • 9.3.3.6.1 Lu-177 market, 2016 - 2027 (USD Million)
      • 9.3.3.7 Other beta emitters
      • 9.3.3.7.1 Other beta emitters market, 2016 - 2027 (USD Million)
    • 9.3.4 Brachytherapy
      • 9.3.4.1 Brachytherapy market, 2016 - 2027 (USD Million)
      • 9.3.4.2 Cesium-131
      • 9.3.4.2.1 Cesium-131 market, 2016 - 2027 (USD Million)
      • 9.3.4.3 Iodine-125
      • 9.3.4.3.1 Iodine-125 market, 2016 - 2027 (USD Million)
      • 9.3.4.4 Palladium-103
      • 9.3.4.4.1 Palladium-103 market, 2016 - 2027 (USD Million)
      • 9.3.4.5 Iridium-192
      • 9.3.4.5.1 Iridium-192 market, 2016 - 2027 (USD Million)
      • 9.3.4.6 Other brachytherapy products
      • 9.3.4.6.1 Other brachytherapy products market, 2016 - 2027 (USD Million)

Chapter 10 Application Mode Business Analysis

  • 10.1 Radiopharmaceuticals/Nuclear Medicine Market: Application Movement Analysis
    • 10.1.1 Cardiology
      • 10.1.1.1 Cardiology applications market, 2016 - 2027 (USD Million)
    • 10.1.2 Neurology
      • 10.1.2.1 Neurology applications market, 2016 - 2027 (USD Million)
    • 10.1.3 Oncology
      • 10.1.3.1 Oncology applications market, 2016 - 2027 (USD Million)
    • 10.1.4 Thyroid
      • 10.1.4.1 Thyroid applications market, 2016 - 2027 (USD Million)
    • 10.1.5 Lymphoma
      • 10.1.5.1 Lymphoma applications market, 2016 - 2027 (USD Million)
    • 10.1.6 Bone metastasis
      • 10.1.6.1 Bone metastasis applications market, 2016 - 2027 (USD Million)
    • 10.1.7 Endocrine tumor
      • 10.1.7.1 Endocrine tumor market, 2016 - 2027 (USD Million)
    • 10.1.8 Other application
      • 10.1.8.1 Other applications market, 2016 - 2027 (USD Million)

Chapter 11 Regional Business Analysis

  • 11.1 Radiopharmaceuticals/Nuclear Medicine Market: Regional Movement Analysis
  • 11.2 North America
    • 11.2.1 North America Market Estimates And Forecast, 2016 - 2027
    • 11.2.2 U.S.
      • 11.2.2.1 U.S. Market Estimates And Forecast, 2016 - 2027
    • 11.2.3 Canada
      • 11.2.3.1 Canada Market Estimates And Forecast, 2016 - 2027
  • 11.3 Europe
    • 11.3.1 Europe Market Estimates And Forecast, 2016 - 2027
    • 11.3.2 Germany
      • 11.3.2.1 Germany Market Estimates And Forecast, 2016 - 2027
    • 11.3.3 U.K.
      • 11.3.3.1 U.K. Market Estimates And Forecast, 2016 - 2027
    • 11.3.4 France
      • 11.3.4.1 France Market Estimates And Forecast, 2016 - 2027
    • 11.3.5 Italy
      • 11.3.5.1 Italy Market Estimates And Forecast, 2016 - 2027
    • 11.3.6 Spain
      • 11.3.6.1 Spain Market Estimates And Forecast, 2016 - 2027
    • 11.3.7 Russia
      • 11.3.7.1 Russia Market Estimates And Forecast, 2016 - 2027
    • 11.3.8 Netherlands
      • 11.3.8.1 Netherlands Market Estimates And Forecast, 2016 - 2027
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Market Estimates And Forecast, 2016 - 2027
    • 11.4.2 Japan
      • 11.4.2.1 Japan Market Estimates And Forecast, 2016 - 2027
    • 11.4.3 China
      • 11.4.3.1 China Market Estimates And Forecast, 2016 - 2027
    • 11.4.4 India
      • 11.4.4.1 India Market Estimates And Forecast, 2016 - 2027
    • 11.4.5 Australia
      • 11.4.5.1 Australia Market Estimates And Forecast, 2016 - 2027
    • 11.4.6 Singapore
      • 11.4.6.1 Singapore Market Estimates And Forecast, 2016 - 2027
    • 11.4.7 Malaysia
      • 11.4.7.1 Malaysia Market Estimates And Forecast, 2016 - 2027
    • 11.4.8 New Zealand
      • 11.4.8.1 New Zealand Market Estimates And Forecast, 2016 - 2027
    • 11.4.9 South Korea
      • 11.4.9.1 South Korea Market Estimates And Forecast, 2016 - 2027
    • 11.4.10 Philippines
      • 11.4.10.1 Philippines Market Estimates And Forecast, 2016 - 2027
  • 11.5 Latin America
    • 11.5.1 Latin America Market Estimates And Forecast, 2016 - 2027
    • 11.5.2 Brazil
      • 11.5.2.1 Brazil Market Estimates And Forecast, 2016 - 2027
    • 11.5.3 Mexico
      • 11.5.3.1 Mexico Market Estimates And Forecast, 2016 - 2027
    • 11.5.4 Argentina
      • 11.5.4.1 Argentina Market Estimates And Forecast, 2016 - 2027
  • 11.6 Middle East & Africa
    • 11.6.1 Middle-East And Africa Market Estimates And Forecast, 2016 - 2027
    • 11.6.2 Saudi Arabia
      • 11.6.2.1 Saudi Arabia Market Estimates And Forecast, 2016 - 2027
    • 11.6.3 South Africa
      • 11.6.3.1 South Africa Market Estimates And Forecast, 2016 - 2027
    • 11.6.4 Israel
      • 11.6.4.1 Israel Market Estimates And Forecast, 2016 - 2027
    • 11.6.5 Turkey
      • 11.6.5.1 Turkey Market Estimates And Forecast, 2016 - 2027

Chapter 12 Company Profile

  • 12.1 Eckert & Ziegler
      • 12.1.1.1 Company overview
      • 12.1.1.2 Financial performance
      • 12.1.1.3 Product benchmarking
      • 12.1.1.4 Strategic initiatives
  • 12.2 Mallinckrodt
      • 12.1.2.1 Company overview
      • 12.1.2.2 Financial performance
      • 12.1.2.3 Product benchmarking
      • 12.1.2.4 Strategic initiatives
  • 12.3 Curium Pharma
      • 12.1.3.1 Company overview
      • 12.1.3.2 Product benchmarking
      • 12.1.3.3 Strategic initiatives
  • 12.4 GE Healthcare
      • 12.1.4.1 Company overview
      • 12.1.4.2 Financial performance
      • 12.1.4.3 Product benchmarking
      • 12.1.4.4 Strategic initiatives
  • 12.5 Jubilant Pharma. LLC
      • 12.1.5.1 Company overview
      • 12.1.5.2 Financial performance
      • 12.1.5.3 Product benchmarking
      • 12.1.5.4 Strategic initiatives
  • 12.6 Bracco Imaging S.p.A
      • 12.1.6.1 Company overview
      • 12.1.6.2 Product benchmarking
      • 12.1.6.3 Strategic initiatives
  • 12.7 Nordion (Canada) Inc.
      • 12.1.7.1 Company overview
      • 12.1.7.2 Financial performance
      • 12.1.7.3 Product benchmarking
      • 12.1.7.4 Strategic initiatives
  • 12.8 The Institute for Radioelements (IRE - IRE ELiT)
      • 12.1.8.1 Company overview
      • 12.1.8.2 Financial performance
      • 12.1.8.3 Product benchmarking
      • 12.1.8.4 Strategic initiatives
  • 12.9 Australian Nuclear Science & Technology Organization (ANSTO)
      • 12.1.9.1 Company overview
      • 12.1.9.2 Financial performance
      • 12.1.9.3 Product benchmarking
      • 12.1.9.4 STRATEGIC INITIATIVES
  • 12.10 NTP Radioisotopes SOC Ltd.
      • 12.1.10.1 Company overview
      • 12.1.10.2 Financial performance
      • 12.1.10.3 Product benchmarking
      • 12.1.10.4 Strategic initiatives
  • 12.11 Eczacibasi-Monrol
      • 12.1.11.1 Company overview
      • 12.1.11.2 Financial performance
      • 12.1.11.3 Product benchmarking
      • 12.1.11.4 Strategic initiatives
  • 12.12 Lantheus Medical Imaging, Inc.
      • 12.1.12.1 Company overview
      • 12.1.12.2 Financial overview
      • 12.1.12.3 Product benchmarking
      • 12.1.12.4 Strategic initiatives